Background and Objectives | Time Frame |
---|---|
A leading pharmaceutical company wanted to assess the commercial opportunity for an asset for Tourette’s Syndrome (TS). SmartAnalyst was engaged to estimate:
|
16 weeks |
Approach and Recommendations (Methodology) | Results |
The overall approach was based on creation of a bottom-up, patient-based model, which required collation of information obtained from extensive secondary and primary research, and client’s foundational data. SmartAnalyst adopted a four-step process to accomplish the objectives:
Step 1: Current and Evolving Disease Landscape
Step 2: TPP Development and Testing
Step 3: Revenue Forecast
Step 4: Valuation and Scenario Evaluation
|
|